Immediate Impact
1 by Nobel laureates 56 standout
Citing Papers
Targeting the Warburg Effect in Cancer: Where Do We Stand?
2024 Standout
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Works of N. Afonso being referenced
Clinical activity of MCLA-128 (zenocutuzumab), trastuzumab, and vinorelbine in HER2 amplified metastatic breast cancer (MBC) patients (pts) who had progressed on anti-HER2 ADCs.
2020
Chemotherapy (CT) de-escalation using an FDG-PET/CT (F-PET) and pathological response-adapted strategy in HER2[+] early breast cancer (EBC): PHERGain Trial.
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| N. Afonso | 240 | 84 | 61 | 105 | 98 | 28 | 484 | |
| C Andreoli | 224 | 87 | 34 | 141 | 229 | 33 | 566 | |
| Hong Ling | 236 | 74 | 37 | 185 | 184 | 33 | 561 | |
| Sabrina Zanardi | 107 | 23 | 48 | 117 | 52 | 25 | 561 | |
| Ahmed Elkhanany | 227 | 107 | 18 | 163 | 167 | 24 | 508 | |
| Daniel Boehm | 195 | 54 | 37 | 145 | 120 | 25 | 532 | |
| Silverio Tomao | 248 | 60 | 5 | 176 | 75 | 23 | 493 | |
| Yurdanur Süllü | 97 | 56 | 16 | 147 | 131 | 40 | 454 | |
| Yan Wu | 184 | 140 | 13 | 107 | 48 | 30 | 425 | |
| Anna Park | 135 | 34 | 16 | 43 | 284 | 23 | 506 | |
| Elsa Curtit | 207 | 101 | 6 | 74 | 111 | 45 | 423 |
All Works
Loading papers...